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Abuse of androgenic and anabolic steroids is becoming both a medical and
public health problem. It is generally underestimated just how prevalent steroid
abuse is amongst young sports people. Vascular thrombosis (myocardial
infarction,' stroke,2 arterial thrombosis in a limb3) has been documented in the
USAinsteroid abusing athletesinthepastdecade. Theproblem isnowappearing
in Britain, andtwo cases ofmyocardial infarction andoneofpulmonary embolus
associated with steroid abuse have been documented since 1990.
CASE REPORT. A 24 year old competitive bodybuilder presented three days
after development of recurrent, dull central chest pain radiating to his left arm.
He had been aware ofsimilar, less severe episodes over the previous six weeks,
which he had attributed to muscular strain after heavy weight-training. He
spontaneously admitted to use of anabolic steroids for two years - taking
multiple steroid preparations in mixed dosage forms, both orally and by
intramuscular injection, at high doses for a prolonged period - a process called
"stacking and cycling" by those involved.4
Over the last six week cycle he had been taking oral stanozolol 40 mgs daily,
nandrolone 200 mgs intramuscularly twice weekly, and Sustanon 250
(testosterone esters) I ml intramuscularly once a week. He also smoked 30
cigarettes daily - a 10 year habit. There was no family history of heart disease
or lipid disorder.
Serial electrocardiographs and cardiac enzyme measurementsconfirmed lateral
myocardial infarction. Serum creatine kinase (myocardial subfraction) rose
from 42 to 68 units in 24 hours and fell to 33 by 48 hours. The percentage ofthis
enzyme rise increased from 6 to 14%. (More than a 7% rise is diagnostic of
myocardial necrosis). Fasting lipid measurements showed a raised serum total
cholesterol (8.5 mmol/l) and low HDL cholesterol (0.7 mmol/l),giving a ratio of
12:1 (the normal ratio is less than 6:1). Fasting serum triglyceride was 1.65
mmol/l (normal range 1.2 -3.0 mmol/l).
Echocardiogram showed a normal sized heart with good left ventricular function
and a small area of apical infarction. Exercise stress testing under the modified
Bruce protocol gave a total exercise time of 17 minutes, without chest pain and
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the test was terminated due to fatigue. Blood pressure and pulse rate rose with
exercise as would occur in a normal healthy individual. At submaximal exercise
he developed frequent ventricular ectopic beats with couplets and bigeminy.
These ectopic beats decreased at peak exercise and recurred again in the early
recovery period. He also developed STsegment elevation in standard lead 1 and
the anterolateral chest leads, which reverted to normal after six minutes.
Hisbloodpressureremainedintermittentlyelevated (maximum 195/1 10mmHq)
and he was treated with atenolol 100 mg daily and aspirin. He was not started on
acholesterol-lowering agentasthelipidprofile shouldimprove oncetheanabolic
steroids are discontinued. He was advised to stop all steroid abuse, to stop
smoking, to avoid weight-training, and was encouraged to do moderate aerobic
exercise. He is awaiting coronary angiography.
DISCUSSION
Although hypertension and adverse lipidprofiles arewell established side effects
of anabolic steroid overdose, acute thrombosis has been linked only recently to
androgen abuse. Thereisnodirectevidencethatthesesteroidsarethrombogenic
but experimental data suggests they probably facilitate thrombosis by an effect
onplateletaggregationandoncoagulationproteins.567 Inthiscasetheaetiological
factors favouring thrombosis would seem to be the adverse lipid profile and
hypertension conferred by use of steroids; anabolic exercise (weight training in
itself imparts a negative effect on lipids which is amplified when abusing
steroids); cigarette smoking; and the possibility of steroids affecting platelet
function and the clotting factors. At a molecular level steroid abuse produces
mitochondrial and myofibrillar changes similar to those seen in early heart
failure.8 In athletes who die suddenly there is a higher incidence of right
ventricular cardiomyopathy, although there is no direct evidence to link this to
steroid abuse. Echocardiographic studies show concentric left ventricular
hypertrophy and altered pressure-volume relationships within the heart, but in
comparative studies between steroid-users andnon steroid-users no statistically
significant difference in left ventricular function could be found.9
It is well known that serious side-effects can be attributed to anabolic steroids.
These may occur within weeks (decreased reproductive function, altered serum
transaminases or deleterious lipid profile) or take years to develop, such as
hepatocellular carcinoma. All the early side-effects are reversible provided the
drug abuse is discontinued. Greater public awareness of the problem of steroid
misuse is necessary. By and large, the medical community do not recognise the
wide availability of the compounds or the prevalence of their misuse.
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